These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7983382)

  • 1. Systematic identification of H-2 Kd binding peptides and induction of peptide specific CTL.
    Gill RF; Abastado JP; Wei WZ
    J Immunol Methods; 1994 Dec; 176(2):245-53. PubMed ID: 7983382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D.
    Mata M; Travers PJ; Liu Q; Frankel FR; Paterson Y
    J Immunol; 1998 Sep; 161(6):2985-93. PubMed ID: 9743362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.
    Rice J; Elliott T; Buchan S; Stevenson FK
    J Immunol; 2001 Aug; 167(3):1558-65. PubMed ID: 11466377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity.
    Feltkamp MC; Vierboom MP; Kast WM; Melief CJ
    Mol Immunol; 1994 Dec; 31(18):1391-401. PubMed ID: 7823965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T-cells specific for natural IgE peptides downregulate IgE production.
    Chen SS; Gong J; Yang YM; Oettgen H; Zanetti M
    Cell Immunol; 2005 Jan; 233(1):11-22. PubMed ID: 15913585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cytotoxic T lymphocytes to murine mammary tumor cells with a Kd-restricted immunogenic peptide.
    Wei WZ; Gill RF; Jones RF; Lichlyter D; Abastado JP
    Int J Cancer; 1996 May; 66(5):659-63. PubMed ID: 8647629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides.
    Bertholet S; Iggo R; Corradin G
    Eur J Immunol; 1997 Mar; 27(3):798-801. PubMed ID: 9079825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis.
    Fonseca DP; Joosten D; Snippe H; Verheul AF
    Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of MHC class I H-2 Kb/Db-restricted immunogenic peptides derived from retinal proteins.
    Wang M; Bai F; Pries M; Buus S; Prause JU; Nissen MH
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3939-45. PubMed ID: 16936108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient in vivo induction of CTL by cell-associated covalent H-2Kd-peptide complexes.
    Romero P; Cerottini JC; Luescher IF
    J Immunol Methods; 1994 May; 171(1):73-84. PubMed ID: 8176239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface.
    Anjuère F; Horvath C; Cerottini JC; Luescher IF
    Eur J Immunol; 1995 Jun; 25(6):1535-40. PubMed ID: 7614979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
    Quinn A; McInerney MF; Sercarz EE
    J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density.
    Motta I; Lone YC; Kourilsky P
    Eur J Immunol; 1998 Nov; 28(11):3685-95. PubMed ID: 9842911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA.
    Maryanski JL; Pala P; Cerottini JC; Corradin G
    J Exp Med; 1988 Apr; 167(4):1391-405. PubMed ID: 3128632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition between unrelated peptides recognized by H-2-Kd restricted T cells.
    Pala P; Bodmer HC; Pemberton RM; Cerottini JC; Maryanski JL; Askonas BA
    J Immunol; 1988 Oct; 141(7):2289-94. PubMed ID: 2459204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.